Survival rate for stage 4 lymphoma
Survival duration for stage 4 lymphoma varies depending on the specific type. After aggressive treatment, the 5-year survival rate is generally around 25%–30%. However, the actual prognosis depends on the individual patient's condition.
Lymphoma is a common type of tumor and can be classified into stage 1, stage 2, stage 3, and stage 4 based on the extent of disease. In advanced cases, cancer cells spread and metastasize to one or more extranodal organs—such as blood, liver, or bone marrow—forming multiple tumor lesions, or involve extensive lymph node infiltration.
Once lymphoma is pathologically confirmed, multiple immunohistochemical tests are required. Lymphomas are highly heterogeneous, leading to different treatment approaches and prognoses. The survival time for stage 4 lymphoma varies significantly among different pathological subtypes. Overall, the 5-year survival rate for Hodgkin lymphoma is approximately 30%, while for non-Hodgkin lymphoma it is around 25%. Patients presenting systemic symptoms such as fever, night sweats, and weight loss tend to have shorter survival compared to those without such symptoms. Additionally, both children and elderly patients generally have poorer prognoses.
To prevent disease progression, regular physical examinations are important. Any abnormal lumps or bodily changes should be evaluated by a healthcare professional promptly.